J.T.J.N. Hiltermann - Concepedia

Concepedia

Author

J.T.J.N. Hiltermann

Asklepios Fachkliniken München-Gauting

Also Known As

J T Hiltermann, J.T.J.N. Hiltermann, Jeroen Hiltermann, Jeroen T. Hiltermann

19

Publications

2.9K

Citations

5

H-Index

14

Concepts

All Affiliations

Asklepios Fachkliniken München-Gauting Hospital Universitario 12 De Octubre Ospedale Vincenzo Cervello Okayama University Hospital AstraZeneca (United States)

JH

About

J.T.J.N. Hiltermann is an author at Asklepios Fachkliniken München-Gauting specializing in medicine, cancer therapeutics, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	2.9K
2	Allergy	1	1	160
3	Allergy Medicine	1	1	160
4	Immunology	1	1	160
5	Pathology	1	1	662

J.T.J.N. Hiltermann

×

3

Publications

2.9K

Citations

3

H-Index

	Year	Citations
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen, The Lancet Platinum–etoposide Versus Platinum–etoposideMedicinePharmacologyImmune Checkpoint InhibitorFirst-line Treatment	2019	2.1K
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen, The Lancet Oncology Platinum–etoposide Versus Platinum–etoposideMedicinePathologyImmune Checkpoint InhibitorFirst-line Treatment	2020	662
The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma. Zuzana Diamant, J.T.J.N. Hiltermann, E.L. van Rensen, American Journal of Respiratory and Critical Care Medicine InflammationAsthmaCysteinyl Leukotriene Lte4Inflammatory CellsInflammatory Lung Disease	1997	160

Page 1